tiprankstipranks
Anika Therapeutics reports Q1 adjusted EPS (6c) vs. 13c last year
PremiumThe FlyAnika Therapeutics reports Q1 adjusted EPS (6c) vs. 13c last year
2M ago
Anika Therapeutics sees FY25 adjusted EBITDA down 3% to up 3%
Premium
The Fly
Anika Therapeutics sees FY25 adjusted EBITDA down 3% to up 3%
2M ago
Is ANIK a Buy, Before Earnings?
Premium
Pre-Earnings
Is ANIK a Buy, Before Earnings?
2M ago
Anika Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsAnika Therapeutics’ Earnings Call: Growth Amid Challenges
4M ago
Anika Therapeutics price target lowered to $20 from $25 at Barrington
Premium
The Fly
Anika Therapeutics price target lowered to $20 from $25 at Barrington
4M ago
Anika Therapeutics Reports Steady Growth and Strategic Focus
Premium
Company Announcements
Anika Therapeutics Reports Steady Growth and Strategic Focus
4M ago
Anika Therapeutics price target lowered to $25 from $37 at Barrington
PremiumThe FlyAnika Therapeutics price target lowered to $25 from $37 at Barrington
8M ago
Anika Therapeutics Focuses on Core Growth Amid Restructuring
Premium
Company Announcements
Anika Therapeutics Focuses on Core Growth Amid Restructuring
8M ago
Anika Therapeutics Refocuses on Core Technology and Growth
Premium
Company Announcements
Anika Therapeutics Refocuses on Core Technology and Growth
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100